BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26083652)

  • 1. Mechanisms of Cachexia in Chronic Disease States.
    Yoshida T; Delafontaine P
    Am J Med Sci; 2015 Oct; 350(4):250-6. PubMed ID: 26083652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
    Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.
    Delafontaine P; Yoshida T
    Trans Am Clin Climatol Assoc; 2016; 127():245-258. PubMed ID: 28066057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.
    Yoshida T; Galvez S; Tiwari S; Rezk BM; Semprun-Prieto L; Higashi Y; Sukhanov S; Yablonka-Reuveni Z; Delafontaine P
    J Biol Chem; 2013 Aug; 288(33):23823-32. PubMed ID: 23831688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy.
    Rezk BM; Yoshida T; Semprun-Prieto L; Higashi Y; Sukhanov S; Delafontaine P
    PLoS One; 2012; 7(1):e30276. PubMed ID: 22276172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.
    Yoshida T; Semprun-Prieto L; Wainford RD; Sukhanov S; Kapusta DR; Delafontaine P
    Endocrinology; 2012 Mar; 153(3):1411-20. PubMed ID: 22234465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
    Sanders PM; Russell ST; Tisdale MJ
    Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II: role in skeletal muscle atrophy.
    Cabello-Verrugio C; Córdova G; Salas JD
    Curr Protein Pept Sci; 2012 Sep; 13(6):560-9. PubMed ID: 22974090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II, oxidative stress and skeletal muscle wasting.
    Sukhanov S; Semprun-Prieto L; Yoshida T; Michael Tabony A; Higashi Y; Galvez S; Delafontaine P
    Am J Med Sci; 2011 Aug; 342(2):143-7. PubMed ID: 21747283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I.
    Brink M; Price SR; Chrast J; Bailey JL; Anwar A; Mitch WE; Delafontaine P
    Endocrinology; 2001 Apr; 142(4):1489-96. PubMed ID: 11250929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
    Song YH; Li Y; Du J; Mitch WE; Rosenthal N; Delafontaine P
    J Clin Invest; 2005 Feb; 115(2):451-8. PubMed ID: 15650772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting.
    Tabony AM; Yoshida T; Galvez S; Higashi Y; Sukhanov S; Chandrasekar B; Mitch WE; Delafontaine P
    Hypertension; 2011 Oct; 58(4):643-9. PubMed ID: 21844485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration.
    Yoshida T; Huq TS; Delafontaine P
    J Biol Chem; 2014 Sep; 289(38):26239-26248. PubMed ID: 25112871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle wasting in cancer.
    Johns N; Stephens NA; Fearon KC
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure.
    Yoshida T; Delafontaine P
    J Biol Chem; 2016 Dec; 291(49):25578-25590. PubMed ID: 27756842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression.
    Du Bois P; Pablo Tortola C; Lodka D; Kny M; Schmidt F; Song K; Schmidt S; Bassel-Duby R; Olson EN; Fielitz J
    Circ Res; 2015 Aug; 117(5):424-36. PubMed ID: 26137861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waste management - cytokines, growth factors and cachexia.
    Saini A; Al-Shanti N; Stewart CE
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
    Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K
    Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.